{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:11:11Z","timestamp":1792815071603,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ebiom.2020.102783","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T12:09:17Z","timestamp":1590235757000},"page":"102783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model"],"prefix":"10.1016","volume":"56","author":[{"given":"Katrin","family":"Kleinmanns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Fosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira Garc\u00eda","family":"de Jal\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Tenstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7621-4625","authenticated-orcid":false,"given":"Emmet","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10177","key":"10.1016\/j.ebiom.2020.102783_bib0001","first-page":"1240","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"393","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102783_bib0002","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102783_bib0003","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ebiom.2020.102783_bib0004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijgo.12614","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"143","author":"Berek","year":"2018","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102783_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ygyno.2018.06.002","article-title":"Factors that influence survival in high-grade serous ovarian cancer: a complex relationship between molecular subtype, disease dissemination, and operability","volume":"150","author":"Torres","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102783_bib0006","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1038\/s41467-018-04987-y","article-title":"FABP4 as a key determinant of metastatic potential of ovarian cancer","volume":"9","author":"Gharpure","year":"2018","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.ebiom.2020.102783_bib0007","article-title":"TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO\u2010OVAR OP7)","volume":"35","author":"Mahner","year":"2017","journal-title":"Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102783_bib0008","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3390\/ijms20122927","article-title":"Ovarian cancer immunotherapy: turning up the heat","volume":"20","author":"Ghisoni","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102783_bib0009","doi-asserted-by":"crossref","first-page":"dju048","DOI":"10.1093\/jnci\/dju048","article-title":"Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples","volume":"106","author":"Riester","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102783_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2010.47","article-title":"Imaging ovarian cancer and peritoneal metastases\u2014current and emerging techniques","volume":"7","author":"Kyriazi","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102783_bib0011","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrclinonc.2013.123","article-title":"Image-guided cancer surgery using near-infrared fluorescence","volume":"10","author":"Vahrmeijer","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102783_bib0012","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/SLA.0000000000002127","article-title":"Oncologic procedures amenable to fluorescence-guided surgery","volume":"266","author":"Tipirneni","year":"2017","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102783_bib0013","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S1470-2045(19)30317-1","article-title":"Latest developments in molecular tracers for fluorescence image-guided cancer surgery","volume":"20","author":"Hernot","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2020.102783_bib0014","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fphar.2019.00510","article-title":"Emerging fluorescent molecular tracers to guide intra-operative surgical decision-making","volume":"10","author":"Debie","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102783_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm0103-123","article-title":"Shedding light onto live molecular targets","volume":"9","author":"Weissleder","year":"2003","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102783_bib0016","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.2472","article-title":"Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results","volume":"17","author":"van Dam","year":"2011","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.ebiom.2020.102783_bib0017","doi-asserted-by":"crossref","first-page":"32144","DOI":"10.18632\/oncotarget.8282","article-title":"Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17","volume":"7","author":"Tummers","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102783_bib0018","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/1078-0432.CCR-15-2640","article-title":"A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer","volume":"22","author":"Hoogstins","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2020.102783_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2019.07.010","article-title":"A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer","author":"Randall","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102783_bib0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/acs.molpharmaceut.6b01053","article-title":"Effect of dye and conjugation chemistry on the biodistribution profile of near-infrared-labeled nanobodies as tracers for image-guided surgery","volume":"14","author":"Debie","year":"2017","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102783_bib0021","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/s41467-018-05113-8","article-title":"NIR-II nanoprobes in-vivo assembly to improve image-guided surgery for metastatic ovarian cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102783_bib0022","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1021\/acsnano.8b09829","article-title":"Real-time single-walled carbon nanotube-based fluorescence imaging improves survival after debulking surgery in an ovarian cancer model","volume":"13","author":"Ceppi","year":"2019","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102783_bib0023","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2967\/jnumed.111.092833","article-title":"Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies","volume":"52","author":"van Scheltinga","year":"2011","journal-title":"J Nucl Med"},{"issue":"18","key":"10.1016\/j.ebiom.2020.102783_bib0024","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2020.102783_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102782","article-title":"CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma","volume":"56","author":"Kleinmanns","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102783_bib0026","doi-asserted-by":"crossref","first-page":"e89527","DOI":"10.1371\/journal.pone.0089527","article-title":"First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma","volume":"9","author":"Helland","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102783_bib0027","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","article-title":"Principles and approaches for reproducible scoring of tissue stains in research","volume":"98","author":"Meyerholz","year":"2018","journal-title":"Lab Investig"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102783_bib0028","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1182\/blood-2012-05-429555","article-title":"Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia","volume":"121","author":"McCormack","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102783_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05727-y","article-title":"Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers","volume":"9","author":"Koller","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102783_bib0030","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3892\/or.2017.5583","article-title":"CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways","volume":"37","author":"Nakamura","year":"2017","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102783_bib0031","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","article-title":"CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival","volume":"161","author":"Kristiansen","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ebiom.2020.102783_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2016.08.005","article-title":"CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells","volume":"58","author":"Davidson","year":"2016","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102783_bib0033","first-page":"1149","article-title":"CD24 overexpression in cancer development and progression: a meta-analysis","volume":"22","author":"Lee","year":"2009","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102783_bib0034","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/jcp.27581","article-title":"Overview of CD24 as a new molecular marker in ovarian cancer","volume":"234","author":"Tarhriz","year":"2019","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102783_bib0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/ijms20030660","article-title":"Characterization of a novel third-generation anti-CD24-CAR against ovarian cancer","volume":"20","author":"Klapdor","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7769","key":"10.1016\/j.ebiom.2020.102783_bib0036","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102783_bib0037","article-title":"Anti-CD24 antibody-nitric oxide conjugate (ANC) selectively and potently suppresses hepatic carcinoma","author":"Sun","year":"2019","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102783_bib0038","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00432-019-02865-8","article-title":"CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy","volume":"145","author":"Han","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102783_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41551-016-0010","article-title":"Near-infrared fluorophores for biomedical imaging","volume":"1","author":"Hong","year":"2017","journal-title":"Nat Biomed Eng"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102783_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158208","article-title":"The HDACi panobinostat shows growth inhibition both in vitro and in a bioluminescent orthotopic surgical xenograft model of ovarian cancer","volume":"11","author":"Helland","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102783_bib0041","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/cncr.30419","article-title":"Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model","volume":"123","author":"Keating","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102783_bib0042","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jso.25150","article-title":"Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery","volume":"118","author":"Lwin","year":"2018","journal-title":"J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102783_bib0043","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/bjc.2014.567","article-title":"Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An ovarian tumour tissue analysis consortium study","volume":"111","author":"K\u00f6bel","year":"2014","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102783_bib0044","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2017.08.015","article-title":"Characterization of folate receptor alpha (FR\u03b1) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: a phase I expansion study of the FR\u03b1-targeting antibody-drug conjugate mirvetuximab soravtansine","volume":"147","author":"Martin","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"23","key":"10.1016\/j.ebiom.2020.102783_bib0045","doi-asserted-by":"crossref","first-page":"10783","DOI":"10.1158\/0008-5472.CAN-05-0619","article-title":"CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis","volume":"65","author":"Baumann","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102783_bib0046","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3892\/ol.2013.1357","article-title":"Clinical significance of CD24 as a predictor of bladder cancer recurrence","volume":"6","author":"Liu","year":"2013","journal-title":"Oncol Lett"},{"issue":"Suppl 2","key":"10.1016\/j.ebiom.2020.102783_bib0047","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/IGC.0b013e3181bffb3f","article-title":"Prognostic factors for complete debulking in first-and second-line ovarian cancer","volume":"19","author":"Harter","year":"2009","journal-title":"Int J Gynecol Cancer"}],"updated-by":[{"DOI":"10.1016\/j.ebiom.2021.103295","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:00:01Z","timestamp":1762455601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420301584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":47,"alternative-id":["S2352396420301584"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102783","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102783"}}